Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Asset Writedowns and Impairment: 2023-2025

  • Neogen's Asset Writedowns and Impairment rose 107438.67% to $597.9 million in Q2 2025 from the same period last year, while for May 2025 it was $599.9 million, marking a year-over-year change of. This contributed to the annual value of $1.1 billion for FY2025, which is 192120.68% up from last year.
  • Neogen's Asset Writedowns and Impairment amounted to $597.9 million in Q2 2025, which was up 28,183.59% from $2.1 million recorded in Q1 2025.
  • Over the past 5 years, Neogen's Asset Writedowns and Impairment peaked at $597.9 million during Q2 2025, and registered a low of -$716,000 during Q1 2024.
  • In the last 3 years, Neogen's Asset Writedowns and Impairment had a median value of $809,000 in 2023 and averaged $120.1 million.
  • In the last 5 years, Neogen's Asset Writedowns and Impairment slumped by 31.27% in 2024 and then skyrocketed by 107,438.67% in 2025.
  • Neogen's Asset Writedowns and Impairment (Quarterly) stood at $809,000 in 2023, then plummeted by 31.27% to $556,000 in 2024, then soared by 107,438.67% to $597.9 million in 2025.
  • Its last three reported values are $597.9 million in Q2 2025, $2.1 million for Q1 2025, and $556,000 during Q2 2024.